Gena Damento, MD
Ophthalmology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Damento’s office at (415) 600-3901 to ask if they take your plan before you enroll.
California Medical Board record
Licence A151234 · Current
Licensed to practise in California · since 2017 · expires 2027-06-30 · Mayo Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$363,053 in 2024
Medicaid paid $363,053 for 4,436 billed services this clinician did in 2024, up to 96 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 719 | $258,945 |
| Service | 1,269 | $104,109 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 1,645 | $0 |
| Postoperative follow-up visit, normally included in the surgical package, to indicate that an evaluation and management service was performed during a postoperative period for a reason(s) related to the original procedure | 94 | $0 |
| Service | 709 | $0 |
| 2024 | 4,436 | 5 | 96 | $363,053 |
| 2023 | 2,639 | 4 | 71 | $239,848 |
| 2022 | 131 | 3 | 40 | $14,412 |
| 2021 | 47 | 1 | 29 | $1,288 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 509 | $179,549 |
| Service | 735 | $60,299 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 967 | $0 |
| Service | 428 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 43 | $5,757 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 26 | $4,798 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 62 | $3,858 |
2021
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 47 | $1,288 |
Drugs they prescribed that Part D paid
$35,660
Pharmacies billed $35,660 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 496) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
282 generic and 214 brand-name prescriptions · $35,660 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cyclosporine | 27 | $13,769 | $510 |
| Fluorometholone | 29 | $3,481 | $120 |
| Ketorolac Tromethamine | 39 | $2,716 | $70 |
| Prednisolone Acetate | 56 | $2,591 | $46 |
| Dorzolamide-Timolol | 55 | $651 | $12 |
See all 12 drugs
| Cyclosporine | 27 | $13,769 | $510 |
| Fluorometholone | 29 | $3,481 | $120 |
| Ketorolac Tromethamine | 39 | $2,716 | $70 |
| Prednisolone Acetate | 56 | $2,591 | $46 |
| Dorzolamide-Timolol | 55 | $651 | $12 |
| Latanoprost | 75 | $579 | $8 |
| Erythromycin | 45 | $441 | $10 |
| Ofloxacin | 44 | $271 | $6 |
| Brimonidine | 29 | $213 | $7 |
| Cromolyn | 15 | $197 | $13 |
| Timolol Maleate | 24 | $172 | $7 |
| Neomycin-Polymyxin-Dexameth | 14 | $109 | $8 |
Year by year
| 2024 | 496 | 139 | 0% (0) | 43% | $35,660 |
| 2023 | 765 | 211 | 0% (0) | 41% | $37,949 |
| 2022 | 216 | 90 | 0% (0) | 37% | $10,247 |
| 2021 | 71 | 35 | 0% (0) | 39% | $3,810 |
| 2020 | 146 | 55 | None | 25% | $5,705 |
| 2019 | 134 | 30 | 0% (0) | 22% | $3,628 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Ketorolac Tromethamine | 111 | $8,876 | $80 |
| Prednisolone Acetate | 118 | $6,494 | $55 |
| Fluorometholone | 23 | $3,011 | $131 |
| Latanoprost | 89 | $1,752 | $20 |
| Olopatadine | 53 | $1,550 | $29 |
| Ofloxacin | 102 | $1,440 | $14 |
| Dorzolamide-Timolol | 31 | $1,072 | $35 |
| Timolol Maleate | 56 | $832 | $15 |
| Erythromycin | 65 | $703 | $11 |
| Brimonidine | 36 | $693 | $19 |
| Cromolyn | 12 | $282 | $23 |
| Neomycin-Polymyxin-Dexameth | 16 | $199 | $12 |
2022: 8 drugs
| Prednisolone Acetate | 38 | $2,407 | $63 |
| Ketorolac Tromethamine | 30 | $2,314 | $77 |
| Dorzolamide-Timolol | 15 | $908 | $61 |
| Brimonidine | 18 | $536 | $30 |
| Latanoprost | 23 | $423 | $18 |
| Ofloxacin | 34 | $351 | $10 |
| Erythromycin | 18 | $168 | $9 |
| Timolol Maleate | 12 | $102 | $9 |
2021: 2 drugs
| Brimonidine | 11 | $946 | $86 |
| Prednisolone Acetate | 13 | $747 | $57 |
2020: 5 drugs
| Prednisolone Acetate | 19 | $944 | $50 |
| Erythromycin | 23 | $393 | $17 |
| Latanoprost | 17 | $190 | $11 |
| Olopatadine | 11 | $186 | $17 |
| Brimonidine | 17 | $115 | $7 |
2019: 3 drugs
| Latanoprost | 42 | $582 | $14 |
| Brimonidine | 39 | $494 | $13 |
| Dorzolamide | 15 | $452 | $30 |
Money from drug and device companies
$82 in 2024
| 2024 | 1 | 1 | None | $82 |
| 2022 | 3 | 4 | None | $77 |
| 2021 | 3 | 5 | None | $391 |
| 2020 | 1 | 4 | None | $201 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sight Sciences | Omni Surgical System | $82 | 1 payment
|
See the published payment
| Sight Sciences | Meals · 2024-08-10 | Omni Surgical System | $82 |
See earlier years (2022, 2021, 2020)
2022: $77
| Alcon Vision | Centurion | $44 | 2 payments
|
| Johnson & Johnson Surgical Vision | None | $17 | 1 payment
|
| Glaukos | Istent Inject W | $16 | 1 payment
|
2021: $391
| Alcon Vision | Acrysof Iq Panoptix | $246 | 3 payments
|
| Allergan | Xen Glaucoma Treatment System | $121 | 1 payment
|
| Sight Sciences | Omni(R) Surgical System (US) | $24 | 1 payment
|
2020: $201
| Alcon Vision | Acrysof Iq Panoptix | $201 | 4 payments
|
Professional record
- NPI
- 1013379189
- Licence
- CA A151234California A151234: Current · expires 2027-06-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 711 Van Ness Ave Ste 250, San Francisco, CA, 94102
- NPI first listed
- 2016-03-28
- NPI last updated
- 2021-12-20
- NPI record certified
- 2021-03-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 751 S Bascom Ave, San Jose, CA, 95128
This office lists an electronic records connection.